At the annual Purple Promise Foundation board meeting in November, the board approved funding for a two-year grant to support melanoma research at Atrium Health Levine Cancer Institute.

The $100,000 grant will be used to study ways in which medical professionals redirect immunotherapy for recurring melanoma in patients. This innovative melanoma research study will be led by David Foureau, PhD, Jennifer Atlas, MD, and Asim Amin, MD PhD at Levine Cancer Institute in Charlotte, NC. The research will be performed in collaboration with the Levine Cancer Institute Cancer Genomic Laboratory led by Dr. Nury Steuerwald, PhD, and the bioinformatic group at Wake Forest Cancer Center led by Wei Zhang, PhD.

We want to thank everyone at Atrium Health Foundation, the countless doctors and medical professionals at Atrium Health Levine Cancer Institute for their continued efforts in working to eradicate this awful disease, and all of our donors for their support in our mission to end melanoma.

We could not think of a better way to begin the year, than by celebrating this amazing milestone in the fight against melanoma!

We look forward to all that we can accomplish together in 2024!